Top 5 Biotech Startup Investors in Luxembourg in January 2026
A list of 5 angel investors and VC (Venture Capital) funds that invest in Biotech startups based in Luxembourg. We rank investors based on the number of investments they made in Biotech companies from Luxembourg. We update this investor list every month.Top 5 Biotech Startup Investors in Luxembourg in January 2026
| Investor | Biotech Luxembourg investments |
|---|---|
| Expon Capital | 2 |
| Atlantic Bridge | 1 |
| Be Angels | 1 |
| Expansion Ventures | 1 |
| KHAN Technology Transfer Fund | 1 |
Global investor in big ideas with the potential for positive impact & exponential growth
Show more
Investment focus
- Software, E-Commerce, Financial Services
- Seed, Series A, Series B
- Luxembourg, France, United States
Portfolio highlights
- ClimateCamp — Looking for a sustainable way to collaborate with your suppliers on emissions reduction projects? Look no further than our platform - Book a demo for free!
- Invitrolize — Our human in vitro model allows for the first time the identification and differentiation of respiratory sensitizers and respiratory irritants under air-liquid interphase realistic exposure conditions.
- Exobiosphere — Exobiosphere is a cutting-edge company operating at the intersection of space exploration and biotechnology.
Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.
Show more
Investment focus
- Software, Artificial Intelligence, Analytics
- Series A, Series B, Funding Round
- United States, Ireland, United Kingdom
Portfolio highlights
- SOC Prime — SOC Prime is the only Threat Detection Marketplace where researchers monetize their content to help security teams defend against attacks faster and more efficiently than ever. Powered by its Detection as Code platform, SOC Prime curates the most up-to-date Sigma-based threat detection content from over 300 researchers and natively delivers it viasubscription to 20+ SIEM and XDR platforms at more than 6,000 enterprises, governments and MDRs worldwide.
- Insight Terra — Insight Terra supports data driven risk management in critical situations where business operations, people and the environment all come together.
- Output Sports — Discover Output's portable and affordable athlete testing and tracking device. Measure strength, power and speed in minutes giving accurate and reliable data.
Early stage Entrepreneurs Coaching and FinancingOne of Europe's leading Business Angels Networks. We connect innovative growth companies to equity finance and coaching by experienced angel investors.
The network is 250 members strong and has been assisting innovative entrepreneurs to find financing for more than 10 millions Euros in thelast 4 years.
Show more
Investment focus
- Software, Information Technology, SaaS
- Seed, Pre-Seed, Funding Round
- Belgium, France, Spain
Portfolio highlights
- Savics — Savics offers digital solutions for health actors to improve their data management, disease diagnostics and GeneXpert connectivity.
- DeftHedge — DeftHedge is an application addressed to business leaders, and CFOs facing volatility of foreign exchange market.
- NIUM — NIUM is a startup focused on personalized nutrition and gut microbiome research. NIUM created science-based solutions to transform nutrition research and product development.
Expansion is an venture fund to support European Aerospace & Defence startups.
Show more
Investment focus
- Aerospace, Space Travel, Cyber Security
- Seed, Series B
- France, Spain
Portfolio highlights
- ION-X — Based on patented technology, our unique ionic liquid electrospray thrusters is the next big thing in small satellites propulsion.
- U-Space — U-Space Nanosatellites specializes in the design and manufacturing of next-generation nanosatellites tailored for a variety of applications including commercial services, scientific missions, and defense projects. With a focus on innovation, U-Space offers turnkey solutions encompassing a range of nanosatellite sizes such as 3U, 6U, and 12Uconfigurations. The company is dedicated to transforming client needs into high-performance space systems, marking significant milestones in the space industry with projects like the launch of NESS. U-Space collaborates with partners for components supply, contributing to the development of the French space sector and aiming to lead in nanosatellite constellations by 2025.
- UNIVITY — We envision bringing high speed / low latency connectivity anywhere in the world.
KHAN Technology Transfer Fund operates as an investment firm.
Show more
Investment focus
- Medical, Biotechnology, Pharmaceutical
- Seed, Series A, Funding Round
- Germany, Luxembourg, Czech Republic
Portfolio highlights
- Nodus Oncology — Nodus Oncology Developing the DDR targeting therapies.
- Casinvent Pharma — Casinvent Pharma develops new therapeutic options for the treatment of selected malignancies.
- OrganoTherapeutics — Human iPSC-derived Midbrain Organoids. Advanced brain organoid and assembloid models. Research on Parkinson's Disease. Drug and therapeutics research. High-throughput and AI-driven algorithms for organoid data analysis.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
Health Care
EdTech
Venture Capital
Sustainability
Clean Energy
Web3
Art
Organic Food
Big Data
Wellness
Video Games
Publishing
Android
B2B
Food and Beverage
Digital Media
Payments
Real Estate
Finance
Manufacturing
Education
Financial Services
Retail
Construction
Infrastructure
Beauty
Photography
Sports
Biotechnology
Travel
Fitness
Franchise
Recruiting
Hospitality
Mobile Advertising
eSports
Platforms
Cannabis
Mobile
Automotive
Social
Wine And Spirits
Medical Device
Enterprise Software
Crowdfunding
Music
CleanTech
Mobile Apps
Email
Transportation
InsurTech
Enterprise
Social Media
Social Network
Medical
LGBT
Legal
Local
Internet
Film
Oil and Gas
Fashion
Life Science
Theatre
Non Profit
SaaS
Renewable Energy
Sporting Goods
Restaurants
Software
Celebrity
Social Impact
Agriculture (agtech)
Cryptocurrency
Machine Learning
Media (entertainment)
Facebook
Blockchain
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Sri Lanka
Vietnam
Europe
Qatar
Japan
Singapore
Spain
China
Armenia
Saudi Arabia
Oceania
Africa
Ghana
LATAM
Egypt
Asia
Belarus
Hungary
Brazil
Finland
Liechtenstein
France
Panama
Croatia
Gibraltar
Myanmar
Barbados
Lithuania
Georgia
Greece
Malaysia
Czech Republic
Peru
Faroe Islands
Costa Rica
Hong Kong
Liberia
Jersey
Bahrain
Lebanon
Belgium
Norway
Denmark
Mexico
Bermuda
Estonia
Italy
Algeria
Ecuador
Mali
Bulgaria
Philippines
Belize
Chile
Israel
Ethiopia
Togo
Kuwait
Rwanda
Slovenia
Mauritius
Poland
Uganda
Malta
San Marino
Sweden
Morocco
Serbia
Sierra Leone
Thailand
Nicaragua
Tanzania
Uzbekistan
Dominican Republic
Zambia
Bahamas
Turkey
Uruguay
Iraq
Iceland
Tajikistan
Russian Federation
Portugal
Azerbaijan
Nigeria
El Salvador
Puerto Rico
Namibia
Senegal
United Arab Emirates
Zimbabwe
Tunisia
Jamaica
Venezuela
Honduras
Ukraine
Isle of Man
Taiwan
Bolivia
Pakistan
Luxembourg
Albania
Kenya
Romania
Jordan
Grenada
Argentina
Bangladesh
Kazakhstan
Cayman Islands
Cambodia
Cameroon
Cyprus
Oman
Latvia
Austria
Switzerland
Colombia
Seychelles
Guatemala
Marshall Islands
Investors in Luxembourg by industry
Travel
Finance
Social Media
Manufacturing
Mobile
Blockchain
Financial Services
Payments
FinTech
Consumer
Enterprise
Health Care
Energy
Climate
Sustainability
Impact
SaaS
Proptech
Marketplace
Artificial intelligence
Community
Hardware
B2B
Web3
Gaming
Real Estate
Software
Internet
Media (entertainment)
Video Games
Transportation
Social Network
InsurTech
Biotech
Biotechnology